Mycophenolate mofetil Recruiting Phase 3 Trials for Graft Versus Host Disease (GVHD) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02178683Tacrolimus and Mycophenolate Mofetil as Post-Grafting Immunosuppression